Julie Bertrand

15PUBLICATIONS
58CO-AUTHORS
Innate immunityPharmacogenomicsMedical virologyPredictive and prognostic markersMathematical aspects of quantum and conformal field theory, quantum gravity and string theory
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 29, 2026
High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons.

|Aug 23, 2025
Levofloxacin in Bone and Joint Infections: Development of an Application for Model-Informed Precision Dosing.

Léo Mimram, Sophie Magreault, Florian Lemaitre

|Apr 01, 2025
A Viroimmunologic Model to Characterize the Antiviral Effect of Molnupiravir in Outpatients Infected With SARS-CoV-2: Implication for Treatment Duration.

Bach Tran Nguyen, Julie Bertrand, Akosua A Agyeman

|Nov 28, 2024
Isatuximab-dexamethasone-pomalidomide combination effects on serum M protein and PFS in myeloma: Development of a joint model using phase I/II data.

Antoine Pitoy, Solène Desmée, François Riglet

|Jun 06, 2024
Correction: Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models-a New Method Based on Metropolis-Hastings Algorithm.

Mélanie Guhl, Julie Bertrand, Lucie Fayette

|Jun 05, 2024
Joint modeling of monocyte HLA-DR expression trajectories predicts 28-day mortality in severe SARS-CoV-2 patients.

Gaelle Baudemont, Coralie Tardivon, Guillaume Monneret

Pageof 3

Frequent Collaborators

3 joint publications

François Mercier

3 joint publications

Jérémie Guedj

2 joint publications

France Mentré

2 joint publications

Marion Kerioui